We’re thrilled to announce that our Exec Director, Boro Dropulic, will keynote the first Comprehensive Cell Solutions (CCS) summer symposium on July 11! Together, we can accelerate innovation and make treatments affordable globally. #HealthcareInnovation #CGT #PatientAccess New York Blood Center https://lnkd.in/ewYW6Emc https://lnkd.in/ebZ28Gw9 To Attend in NY: https://lnkd.in/gtc4pT3X
About us
New advanced medicines are curing patients of serious diseases. Such medicines will one day be able to cure millions of people suffering from HIV and other infectious diseases, cancer, genetic diseases, and other serious disorders. Together, our community of caregivers, innovators, volunteers, and partners can accelerate the development of these advanced medicines and create access to cures for all patients in need. Imagine a world without disease.
- Website
-
https://www.caringcross.org/
External link for Caring Cross
- Industry
- Research
- Company size
- 2-10 employees
- Headquarters
- Washington DC
- Type
- Nonprofit
Locations
-
Primary
Washington DC, US
Employees at Caring Cross
Updates
-
🚀 Exciting News! 🚀 We're thrilled to announce that Caring Cross is giving a Lightning Talk and sharing a Portfolio Project Presentation for our open-source viral vector manufacturing process at the NIIMBL 2024 National Meeting on June 25 and 26, 2024. We hope to see you there! 👋 #Biologics #Manufacturing #Innovation #NIIMBL2024 #CaringCross NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals
-
Please join us for today's Scientific Seminar Series! CAR T Cell Targeting and Enhancements Presenter: Dr. Avery D. Posey, Jr., PhD Date: Friday, June 21, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #CARTs #CancerTherapy #Innovation https://lnkd.in/eS8VDQkp University of Pennsylvania School of Medicine
-
Please join us for our upcoming Scientific Seminar Series! CAR T Cell Targeting and Enhancements Presenter: Dr. Avery D. Posey, Jr., PhD Date: Friday, June 21, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #CARTs #CancerTherapy #Innovation https://lnkd.in/eS8VDQkp University of Pennsylvania School of Medicine
-
Please join us for today's Technology Education Series! Clinical Advances/Challenges with Gene Editing Presenter: Dr. Kevin Curran, PhD Date: Friday, June 7, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #HealthcareInnovation #GeneModification #GEx https://lnkd.in/eUjiiYtE University of Washington Global Gene Therapy Initiative
-
Please join us for our upcoming Technology Education Series! Clinical Advances/Challenges with GEx Presenter: Dr. Kevin Curran, PhD Date: Friday, June 7, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #HealthcareInnovation #GeneModification #GEx https://lnkd.in/eUjiiYtE University of Washington Global Gene Therapy Initiative
-
Thank you for joining us at #ISCT24! We're thrilled that Caring Cross was featured in two round table sessions, highlighting how our point-of-care, low-cost manufacturing of cell and gene therapies create superior products with equitable access. ISCT, International Society for Cell & Gene Therapy BioCanRx Fundação Oswaldo Cruz (Fiocruz) Global Gene Therapy Initiative
-
Please join us for today's Scientific Seminar! Beyond Efficacy: Safety and Access Issues in Lentiviral Gene Therapy Presenter: Kenneth Cornetta, MD Date: Friday, May 17, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #HealthcareInnovation #GeneTherapy Indiana University School of Medicine
-
Please join us for our upcoming Scientific Seminar! Beyond Efficacy: Safety and Access Issues in Lentiviral Gene Therapy Presenter: Kenneth Cornetta, MD Date: Friday, May 17, 2024 Time: 3:00 PM EST / 12:00 PM PT / 9:00 PM CET Register on https://lnkd.in/di7eDqry #HealthcareInnovation #GeneTherapy Indiana University School of Medicine
-
Ying Xiong, PhD, who directs our Cell and Gene Therapy program and our Scientific Director, Rimas Orentas, PhD, made key presentations at #ASGCT24. Ying presented an oral abstract in the Novel Production Platforms Session demonstrating our cost-effective CAR-T manufacturing process and Rimas presented in a symposium focused on enabling analytics for point-of-care manufacturing. Their presentations highlight our work to enhance access to Cell and Gene Therapy world-wide. #GlobalHealth #CGT #PatientAccess American Society of Gene & Cell Therapy Global Gene Therapy Initiative